Skip to main content
. 2018 Oct 15;3(6):e695. doi: 10.1097/PR9.0000000000000695

Figure 3.

Figure 3.

The preventive gene therapy with HDAd-DRG-GAD67 against neuropathic pain induced by spinal nerve transection (SNT). The mechanical threshold was measured in the bilateral hind paw 14 days after SNT and treatment with 107 Vp (n = 6), 108 Vp (n = 8), and 109 Vp (n = 8) HDAd-DRG-GAD67 groups, which were compared with the vehicle group (n = 6). #P < 0.01 compared with the HDAd-DRG-GAD67 107 Vp group and *P < 0.01 compared with the vehicle group. Bars indicate mean ±SE. DRG, dorsal root ganglion; HDAd, helper-dependent adenovirus.